132 related articles for article (PubMed ID: 3377272)
1. Hemorheologic treatment of cerebral reversible ischemic episodes with pentoxifylline--a prospective study.
Ott E; Körner E; Lechner H
Angiology; 1988 Jun; 39(6):520-5. PubMed ID: 3377272
[TBL] [Abstract][Full Text] [Related]
2. The rheological efficiency of parenteral pentoxifylline (Trental) in patients with ischemic brain lesions. Preliminary results.
Schneider R; Schmid-Schönbein H; Kiesewetter H
Eur Neurol; 1983; 22 Suppl 1():98-104. PubMed ID: 6884407
[TBL] [Abstract][Full Text] [Related]
3. [Hemocoagulation, fibrinolytic and rheologic parameters in ischemic vasculopathy. Effects of pentoxifylline in the treatment of acute cerebral vasculopathy].
Muggeo M; Calabrò A; Businaro V; Patussi L; Volpe A; Signorini GP; Crepaldi G
Ric Clin Lab; 1981; 11 Suppl 1():353-71. PubMed ID: 7188124
[No Abstract] [Full Text] [Related]
4. Results of hemorheologically active treatment with pentoxifylline in patients with cerebrovascular disease.
Schneider R
Angiology; 1989 Nov; 40(11):987-93. PubMed ID: 2817522
[TBL] [Abstract][Full Text] [Related]
5. Pentoxifylline -- a biomedical profile.
Müller R
J Med; 1979; 10(5):307-29. PubMed ID: 393789
[TBL] [Abstract][Full Text] [Related]
6. Pentoxifylline treatment in patients with occlusive peripheral arterial disease. Circulatory changes and effects on prostaglandin synthesis.
Poggesi L; Scarti L; Boddi M; Masotti G; Serneri GG
Angiology; 1985 Sep; 36(9):628-37. PubMed ID: 3901827
[TBL] [Abstract][Full Text] [Related]
7. A controlled trial of pentoxifylline (Trental 400) in intermittent claudication: clinical, haemostatic and rheological effects.
Reilly DT; Quinton DN; Barrie WW
N Z Med J; 1987 Jul; 100(828):445-7. PubMed ID: 3330188
[TBL] [Abstract][Full Text] [Related]
8. [Parenteral pentoxifylline treatment of ischemic cerebrovascular accident. Preliminary results].
Schneider R; Kiesewetter H
Dtsch Med Wochenschr; 1982 Nov; 107(44):1674-7. PubMed ID: 7140544
[TBL] [Abstract][Full Text] [Related]
9. The role of haemorheological factors in the ageing brain: long-term therapy with pentoxifylline ('Trental' 400) in elderly patients with initial mental deterioration.
Parnetti L; Ciuffetti G; Mercuri M; Lupattelli G; Senin U
Pharmatherapeutica; 1986; 4(10):617-27. PubMed ID: 3602014
[TBL] [Abstract][Full Text] [Related]
10. Pentoxifylline in regional cerebral ischemia in cats.
Steen PA; Milde JH; Michenfelder JD
Acta Anaesthesiol Scand; 1982 Feb; 26(1):39-43. PubMed ID: 7072470
[TBL] [Abstract][Full Text] [Related]
11. Failure of pentoxifylline or cilostazol to improve blood and plasma viscosity, fibrinogen, and erythrocyte deformability in claudication.
Dawson DL; Zheng Q; Worthy SA; Charles B; Bradley DV
Angiology; 2002; 53(5):509-20. PubMed ID: 12365857
[TBL] [Abstract][Full Text] [Related]
12. Cerebrovascular circulatory disorders: new aspects of pathophysiology and therapy.
Müller R; Schröer R
J Med; 1979; 10(5):347-64. PubMed ID: 393790
[TBL] [Abstract][Full Text] [Related]
13. Hemorheological effects of pentoxifylline on disturbed flow behavior of blood in patients with cerebrovascular insufficiency.
Ott E; Lechner H; Fazekas F
Eur Neurol; 1983; 22 Suppl 1():105-7. PubMed ID: 6884401
[TBL] [Abstract][Full Text] [Related]
14. [Chronic senile cerebrovascular insufficiency. Effects of suloctidil and pentoxifylline on erythrocyte deformability].
Pilla G; Ciaponi A; Migliavacca A; Bonora C
Ric Clin Lab; 1983; 13 Suppl 3():459-64. PubMed ID: 6324325
[TBL] [Abstract][Full Text] [Related]
15. Preventive treatment of cerebral transient ischemia: comparative randomized trial of pentoxifylline versus conventional antiaggregants.
Herskovits E; Famulari A; Tamaroff L; Gonzalez AM; Vázquez A; Dominguez R; Fraiman H; Vila J
Eur Neurol; 1985; 24(1):73-81. PubMed ID: 3881263
[TBL] [Abstract][Full Text] [Related]
16. Placebo controlled double-blind study of pentoxifylline in sickle cell disease patients.
Manrique RV
J Med; 1987; 18(5-6):277-91. PubMed ID: 3333162
[TBL] [Abstract][Full Text] [Related]
17. Pharmacology of pentoxifylline, a hemorheologic agent for the treatment of intermittent claudication.
Aviado DM; Dettelbach HR
Angiology; 1984 Jul; 35(7):407-17. PubMed ID: 6380349
[TBL] [Abstract][Full Text] [Related]
18. [Pentoxifylline and arterial hypertension in diabetes mellitus: long-term results in randomized groups].
Solerte SB; Adamo S; Viola C; Zambianchi E; Ferrari E
Ric Clin Lab; 1985; 15 Suppl 1():515-26. PubMed ID: 4035232
[TBL] [Abstract][Full Text] [Related]
19. Double-blind, crossover study of the clinical efficacy and the hemorheological effects of pentoxifylline in patients with occlusive arterial disease of the lower limbs.
Strano A; Davi G; Avellone G; Novo S; Pinto A
Angiology; 1984 Jul; 35(7):459-66. PubMed ID: 6380350
[TBL] [Abstract][Full Text] [Related]
20. Effects of pentoxifylline and metabolite on red blood cell deformability as measured by ektacytometry.
Cummings DM; Ballas SK
Angiology; 1990 Feb; 41(2):118-23. PubMed ID: 2306004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
